FOLFIRI regimen as second-line treatment of metastatic gastric cancer: a retrospective analysis of efficacy, safety and prognostic factors. Eur J Oncol [Internet]. 2015 Sep. 21 [cited 2024 Jul. 18];20(1):32-40. Available from: https://mattioli1885journals.com/index.php/EJOEH/article/view/4168